Physician profile
Daniel P Belko
NPI 1881649648
$608.77
in general payments reported to CMS, 2019-2025
5 companies · $468 in 2025
The $468 reported for 2025 was more than what 99% of Anesthesiologist Assistant providers received nationally (typical 2025 total: $34.52).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.75 · 2022: $19.31 · 2023: $17.70 · 2024: $89.14 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $462.10 | 2024-2025 | Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $68.95 | 2021-2025 | Bridion |
| Fisher & Paykel Healthcare INC | $57.70 | 2023-2025 | Fisher & Paykel Healthcare |
| Boston Scientific Corporation | $15.11 | 2025 | Enroute Transcarotid Neuroprotection System |
| Ambu INC. | $4.91 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Belko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.